Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults

Diemert, David J.; Freire, Janaína de Moura; Valente, Vanderson Firmiano; Fraga, Carlos Geraldo; Talles, Frederico; Grahek, Shannon; Campbell, Doreen; Jariwala, Amar; Periago, Maria Victoria; Enk, Martin Johannes; Bethony, Maria Flávia Gazzinelli; Bottazzi, Maria Elena; Hamilton, Robert; Brelsford, Jill; Yakovleva, Anna; Li, Guangzhao; Peng, Jin; Oliveira, Rodrigo Correa de; Hotez, Peter Jay; Bethony, Jeffrey Michael.
Artículo en Inglés | ARCA | ID: arc-26484

Documentos relacionados

  1. Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon.
  2. Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.
  3. Structure of glutathione S-transferase 1 from the major human hookworm parasite Necator americanus (Na-GST-1) in complex with glutathione.
  4. Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus.
  5. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
  6. Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon.
  7. Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine.
  8. X-ray structures of Na-GST-1 and Na-GST-2 two glutathione S-transferase from the human hookworm Necator americanus.
  9. Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.
  10. Expression, purification, and molecular analysis of the Necator americanus glutathione S-transferase 1 (Na-GST-1): a production process developed for a lead candidate recombinant hookworm vaccine antigen.